Mortalidad en gestantes con COVID - 19 durante el periodo 2020-2021 en Latinoamérica

Abstract

Objective: To conduct a review on mortality in pregnant women with COVID-19 during the 2020-2021 period in Latin America. Methods: A systematic review of scientific articles published from January 1, 2020 to December 31, 2021, was carried out in the Medline databases via PubMed, SciELO, Google Scholar. The question was: What is the mortality in pregnant women with COVID-19 during the 2020-2021 period in Latin America? through the controlled descriptors: “Pregnant women”, “COVID-19”, “Mortality”. Population: Pregnant women, Exposure: COVID-19, Outcome: Mortality. Results: One of the most vulnerable populations were pregnant women, as they are more susceptible to developing serious viral infections due to the physiological adaptations that occur during pregnancy. After the selection process, we included 10 studies that showed results. They were developed in pregnant women with a positive COVID-19 test and had a study population varying between 40 and 29,416 participants. Mortality in intensive care units was found to be 49% in Mexico City. A study in 8 Latin American countries reported that 86.4% of women were infected before delivery and 60.3% in the third trimester. Studies coincide in describing comorbidities in pregnant women with COVID-19, among which hypertensive disorders stand out. Conclusion: This study provides information about maternal mortality associated with COVID-19 among women in Latin America. In addition, pregnant women were found to present health barriers to accessing intensive care unit services.